Post-earnings recap
Reported
Thu, Nov 5, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a narrower loss than expected for the third quarter, which led to a positive stock reaction, with shares rising by 1.89%. However, the company did not provide revenue figures or any forward guidance, leaving investors without additional context for future performance. The lack of detailed commentary from management may lead to uncertainty among investors moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.22 | N/A | +14.40% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results.